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Abstract
Background: Previously, we showed that targeted disruption of viral receptor genes in avian leukosis virus (ALV)
subgroups using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9
(Cas9))-based genome editing confers resistance to ALV subgroups B and J. Here, we used the same strategy to
target the receptor expressed by ALV subgroup A (TVA) and generate chicken cells resistant to infection by this
virus.
Results: CRISPR/Cas9-based disruption of exon 2 within the tva gene of DF-1 fibroblasts conferred resistance to
infection by ALV subgroup A regardless of whether frameshift mutations were introduced during editing. Conversely,
overexpression of the wild-type TVA receptor (wtTVA) by tva-modified DF-1 clones restored susceptibility to ALV
subgroup A. The results confirm that exon 2, which contains the low-density lipoprotein receptor class A domain of
TVA, is critical for virus entry. Furthermore, we sequentially modified DF-1 cells by editing the tva, tvb, and Na+/H+
exchange 1 (chNHE1) genes, which are the specific receptors for ALV subgroups A, B, and J, respectively.
Conclusions: Simultaneous editing of multiple receptors to block infection by different subgroups of ALV confirmed
that ALV subgroups A, B, and J do not share host receptors. This strategy could be used to generate cells resistant to
multiple viral pathogens that use distinct receptors for cell entry.
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Introduction
Avian leukosis viruses (ALV) are pathogenic avian retro-
viruses that cause major neoplastic diseases in many
poultry flocks, resulting in significant economic losses to
the global poultry industry [1]. While a number of
poultry breeding companies have been successful at
eradicated ALV infections from flocks, continued spread
of ALV in some Asian countries remains an issue for the
poultry market [2–5].
ALVs are divided into different subgroups based pri-
marily on the sequence of the envelop glycoprotein,
which is the major determinant of the receptor interac-
tions required for virus entry, host range, and virus
neutralization [6]. Each ALV subgroup targets specific
host cell receptors to interact with the envelop glycopro-
teins; thus, viral entry into cells depends largely on dom-
inant expression of a particular host receptor. ALV
subgroup A enters host cells via the TVA receptor,
which is a low-density lipoprotein receptor (LDLR) [7].
ALV subgroups B, D, and E enter cells via the TVB re-
ceptor, a tumor necrosis factor receptor (TNFR)-related
protein [8–10]. ALV subgroup C uses the TVC receptor,
which is related to the mammalian butyrophilins [11],
and ALV subgroup J uses chicken Na+/H+ exchanger
type 1 (chNHE1) [12].
Genetic variations in host receptor genes determine
the susceptibility of chickens to infection by different
ALV subgroups. A single base pair mutation resulting in
a cysteine to tryptophan mutation or a four base pair in-
sertion into exon 1 of the tva gene confers resistence to
ALV subgroup A viruses [13]. In addition, intronic dele-
tions within the tva receptor gene that disrupt mRNA
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splicing confer resistance to ALV subgroup A viruses
[14, 15]. In addition, a naturally occurring premature
stop codon or a single amino acid substitution within
the tvb gene leads to a marked reduction in susceptibil-
ity to ALV subgroups B, D, and E [16, 17]. Furthermore,
a single nucleotide substitution resulting in premature
stop codon in the tvc allele confers resistance to ALV
subgroup C [11]. Finally, the tryptophan residue at pos-
ition 38 (Trp38) of chNHE1 is critical for cell entry by
ALV subgroup J [18].
Genetic analyses by our group led to development of
cell lines that are resistant to infection by ALV sub-
groups B and J [19, 20]. Here, we used the same
CRISPR/Cas9-based editing approach to develop a new
cell line that is resistant to infection by ALV subgroup
A. Furthermore, we applied the technology to perform
sequential disruption of the tva, tvb, and chNHE1 recep-
tors to develop a cell line that is resistant to all three
ALV subgroups.
Materials and methods
Construction of CRISPR/Cas9 expression vectors
We constructed all-in-one CRISPR/Cas9 vectors targeting
tva, with minor modifications. The CRISPR kit used for
constructing multiplex CRISPR/Cas9 vectors was a gift
from Takashi Yamamoto (Addgene Kit #1000000054) [21].
A puromycin resistance gene under the regulation of a
thymidine kinase promoter were inserted into CRISPR/
Cas9 vectors by NotI digestion and ligation (Fig. 1a) (New
England Biolabs, Ipswich, MA, USA). To insert guide
RNA sequences into CRISPR/Cas9 vectors, we synthe-
sized sense and antisense oligonucleotides (Bionics, Seoul,
Korea) and carried out annealing using the following ther-
mocycling conditions: 30 s at 95 °C, 2min at 72 °C, 2min
at 37 °C, and 2min at 25 °C. The oligonucleotides used are
listed in Table 1.
Culture of DF-1 chicken fibroblasts
DF-1 cells were maintained and subpassaged in Dulbecco’s
minimum essential medium (DMEM; Hyclone, Logan,
UT, USA), supplemented with 10% fetal bovine serum
(FBS; Hyclone) and 1× antibiotic–antimycotic (ABAM;
Thermo Fisher–Invitrogen, Carlsbad, CA, USA). DF-1
cells were cultured in an incubator at 37 °C in an atmos-
phere of 5% CO2 at 60%–70% relative humidity.
Transfection and drug selection of DF-1 cells
CRISPR/Cas9 vectors (3 μg) were mixed with Lipofecta-
mine 2000 reagent (Thermo Fisher–Invitrogen) in
Opti-MEM (Thermo Fisher–Invitrogen), and the mixture
was applied to 5 × 105 DF-1 cells. Then, 6 h after transfec-
tion, transfection mixtures were replaced with DF-1 cul-
ture medium. G418 (300 μg/mL) and puromycin (1 μg/
mL) were added to the culture medium 1 d after transfec-
tion. The complete selection period required up to 7 d.
T7E1 assay
Genomic DNA was extracted from DF-1 cells after
puromycin selection. Genomic regions encompassing
the CRISPR/Cas9 target sites were amplified using spe-
cific primer sets. PCR analysis of the targeted loci was
examined in a total volume of 20 μL containing 100 ng
genomic DNA, 10× PCR buffer (BioFACT, Daejeon,
Korea), 0.4 μL dNTPs (10 mmol/L each), 10 pmol of
each primer, and 0.5 U Taq polymerase (BioFACT)
under the following thermocycling conditions: 2 min at
95 °C, followed by 35 cycles of 20 s at 95 °C, 40 s at 65 °C,
and 30 s at 72 °C, and a final 5min at 72 °C. Primers are
listed in Table 1. The PCR amplicons were re-annealed to
form a heteroduplex DNA structure after denaturation.
Subsequently, the heteroduplex amplicons were treated
with 5 units T7E1 endonuclease (New England Biolabs)
for 20min at 37 °C and then analyzed by 1% agarose gel
electrophoresis.
Culture of single DF-1 cells and genomic DNA sequencing
After drug selection, the heterozygous DF-1 cells trans-
fected with each CRISPR/Cas9 vectors were diluted with
DF-1 culture medium concentration at one cell per
100 μL, then single DF-1 cells were seeded in individual
wells of a 96-well plate. We checked the wells each day
after seeding, and when the cells in each well reached con-
fluency, subpassaged the cells into a 48-well plate. These
cells were then used for genomic DNA extraction. The
genomic regions encompassing the target sites in DF-1
were amplified using specific primer sets (Table 1). PCR
analysis of the targeted loci was examined in same condi-
tion with T7E1 analysis. And the PCR products were se-
quenced using the ABI Prism 3730 XL DNA Analyzer
(Thermo Fisher–Applied Biosystems, Foster City, CA,
USA). The sequences were compared against assembled
genomes using NCBI BLAST.
Construction of tva receptor overexpression vector
The wild type TVA coding sequence was cloned from
DF-1 cDNA using wtTVA forward and reverse primers
(Table 1), and cloned into piggyBac-CMV-GFP-FRT vec-
tor [22] by HindIII and NotI digestion and ligation. The
sequences were compared against assembled genomes
using NCBI BLAST.
Sequential disruptions of ALV host receptors and
genomic DNA sequencing
Trp38 of chNHE1-modified DF-1 clone (N3Pss#12) [20]
was transfected with the CRISPR/Cas9 vector targeting
tvb gene (TVB#2) [19]. And the DF-1 was seeded in indi-
vidual wells of a 96-well plate with 100 μL DF-1 culture
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medium. After confirmation of mutations of tvb targeting
region in the DF-1 clones by sequencing analysis, the
CRISPR/Cas9 vectors targeting tva gene were transfected
into the chNHE1 and tvb-modified DF-1 clones subse-
quently and individual DF-1 clones were cultured. And
targeting region of tva gene of the DF-1 clones was ana-
lyzed by sequencing analysis (Fig. 1b).
Virus production and infection
RCAS-A-EGFP DNA, RCAS-B-EGFP DNA and
RCAS-J-EGFP DNA (5 μg each) was mixed with Lipofec-
tamine 2000 reagent (Thermo Fisher–Invitrogen) in
Opti-MEM (Thermo Fisher–Invitrogen) in separate tubes,
and the mixture was applied to 1 × 106 DF-1 cells each.
The mixture was replaced with DF-1 culture medium 6 h
after transfection. One day after transfection, we could
observe green fluorescence in DF-1 cells, indicating virus
production. Cells were passaged, and the medium was
changed 1 d after passaging. One day later, the medium
containing viruses was harvested and frozen at − 70 °C
until further use. For viral infection, the medium contain-
ing viruses was thawed to 37 °C and added to the cultured
individual DF-1 clones. Four days post-infection (dpi),
DF-1 clones were checked under fluorescence microscopy
(TU-80; Nikon, Tokyo, Japan) and analyzed using FACS
Calibur software (BD Biosciences, San Jose, CA, USA).
Amino acid sequence analysis
The amino acid sequences of quail Tva receptor with
four chicken Tva isoforms were aligned using the Uni-
Prot consortium.
Fig. 1 Schematic representation showing genome editing of Avian Leukosis Virus (ALV) host receptors. a DF-1 cells were transfected with CRISPR/
Cas9 vectors containing Cas9 protein-coding sequences, tva-targeting guide RNA, and puromycin resistance genes. After puromycin selection a
T7E1 assay and sequence analysis were performed. In addition, single tva-modified DF-1 cells were cultured the tva gene sequenced. Clones were
then infected with ALV subgroup A produced by RCAS-A-GFP vector-transfected DF-1 cells. b Schematic representation showing sequential
disruption of host receptors for ALV subgroups J, B, and A. TVA, tva targeting gRNA; TVB, tvb targeting gRNA; NHE1, chNHE1 targeting gRNA;
U6, human U6 promoter; CBh, chicken beta-actin short promoter; Amp, ampicillin; Tk, thymidine kinase promoter; Neo, neomycin resistance
gene; Puro, puromycin resistance gene
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Site directed mutagenesis PCR
cDNA encoding full length of TVA receptor cloned in
pGEM T easy vector (Promega) is used as a template. Muta-
tions were introduced by site-directed mutagenesis PCR, a
total volume of 100 μL containing 10 ng template vector,
10× PCR buffer (enzynomics), 0.4 μL dNTPs (10mmol/L
each), 10 pmol of each primer, and 2.5U Pfu polymerase
(enzynomics) under the following thermocycling conditions:
3min at 95 °C, followed by 35 cycles of 30 s at 95 °C, 30 s at
50 °C, and 4min at 72 °C, and a final 15min at 72 °C. 3 types
of primer sets are used and mutagenic oligonucleotides used
are shown in Table 1. The amplicons were treated with 10U
of DpnI enzyme (New England Biolabs) for 1 h at 37 °C and
then purified with Wizard SV Gel and PCR Clean-up system
(Promega). For phosphorylation, 2 μL buffer A (Thermo-
fisher), 10U T4 polynucleotide kinase (Thermofisher), 2 μL
10mmol/L ATP (Thermofisher) and 14 μL of purified DNA
for 1 h at 37 °C. The phosphorylated PCR products were
self-ligated using T4 ligase (Takara), and the mutated TVA
sequences were analyzed using the ABI Prism 3730 XL
DNA Analyzer (Thermo Fisher–Applied Biosystems, Foster
City, CA, USA). Then, the three mutated TVA coding se-
quences were cloned into piggyBac-CMV-GFP-FRT vector
by HindIII and NotI digestion and ligation. The sequences
were compared against assembled genomes using NCBI
BLAST (http://blast.ncbi.nlm.nih.gov).
Statistical analyses
Statistical Analysis System (SAS) software (SAS Institute,
Cary, NC, USA) was used for the analysis of ALV
subgroup A, B and J susceptibility. Treatments were
compared using the least-squares method or Duncan’s
method, and the significance of the main effects was de-
termined using analysis of variance (ANOVA) in the
SAS package. A P-value < 0.05 indicated a statistically
significant difference.
Results
Targeted mutation of the tva gene in chicken DF-1
fibroblasts
To examine whether disrupting the TVA receptor con-
fers resistance to ALV subgroup A, we used the CRISPR/
Cas9 system to introduce a targeted mutation in the tva
gene of chicken DF-1 fibroblasts. First, we constructed
two CRISPR/Cas9 vectors (TVA#1 and TVA#4) target-
ing exon 2 of the tva gene to introduce frameshift muta-
tions into the TVA receptor (Fig. 2a). The CRISPR/Cas9
vectors were then introduced into DF-1 fibroblasts and
transfected cells were selected for drug resistance. The
results of a T7E1 assay showed that cleaved bands were
detected only in DF-1 fibroblasts transfected with each
of the CRISPR/Cas9 vectors, indicating that the
CRISPR/Cas9 vectors efficiently induced nucleic acid
mutations at the targeted locus of the tva gene (Fig. 2b).
Sequence analysis of the targeted locus [10] using the
TA cloning method confirmed that the DF-1 fibroblasts
harbored indel mutations at the targeted regions with
77.8% (7/9) and 66.7% (8/12) efficiency, respectively
(Fig. 2c).
Establishment of tva-modified DF-1 clones and
subsequent challenge with ALV subgroup A
To examine susceptibility of tva-modified DF-1 fibro-
blasts to infection by ALV subgroup A, we generated
single clones from DF-1 fibroblasts transfected with
TVA#1 and TVA#4. We generated eight clones from the
two experimental groups, and sequence analysis of the
PCR products derived from each clone showed that six
of them harbored nucleotide mutations in the tva gene
(Additional file 1: Figure S1). Three of these (TVA#1–6,
TVA#1–8, and TVA#4–4) harbored frameshift muta-
tions (including deleted- or inserted amino acids) at the
targeted locus that generated a premature stop codon in
the tva gene. Three other clones (TVA#1–2, TVA#1–5,
and TVA#1–7) harbored deletion-, insertion- or substi-
tution- at the targeted locus that did not introduce a
frameshift, while two others (TVA#4–2 and TVA#4–9)
harbored the wild-type (WT) tva allele (Table 2).
Next, we infected each DF-1 clone with ALV subgroup
A to examine resistance. Based on expression of green
fluorescent protein (GFP) by the marker virus, we found
that DF-1 clones harboring nucleic acid mutations in the
tva gene (TVA#1–2, TVA#1–5, TVA#1–6, TVA#1–7,
TVA #1–8, and TVA#4–4) did not express GFP,
Table 1 Oligos used in the study





TVA seq F ACACTGACAGCGAGGCGTGC
TVA seq R ACCTCTCCGCACGACGTTCT
wtTVA F AAGCTTCCGGCGGGCCCGGGGCCGGCATG
wtTVA R GCGGCCGCAGGCAAAAAGAGTGAGGGAATTCC
mutaTVA(+ 1) F CTGCGACGATGGACGGGACCGAGTGGGGCTGCGG
AGCGAG
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suggesting that ALV subgroup A did not enter these cells;
by contrast, virus did enter WT DF-1 control cells
(Fig. 3a). Subsequent flow cytometry analysis confirmed
that expression of GFP was significantly higher in DF-1
clones harboring the WT tva gene (TVA#4–2, and
TVA#4–9), indicating that genetic modification of the tva
gene confers resistance to ALV subgroup A, regardless of
the presence of frameshift mutations (Fig. 3b and c). Com-
parative analysis showed that quail Tva and chicken Tva
are highly conserved particularly in the LDLR class A do-
main (LDLa) (Fig. 3d), and the TVA#1–2 clone has muta-
tions on the 64th and 65th positions of Tva amino acid,
TVA#1–5 clone has mutation on the 65th position of Tva
amino acid and TVA#1–7 clone has large deletions on
from 55th to 68th positions of Tva amino acid sequences
(Fig. 3e).
Overexpression of the WT TVA receptor by tva-modified
DF-1 clones restores susceptibility to infection by ALV
subgroup A
Next, we examined whether overexpressing WT TVA re-
stores susceptibility of tva-modified DF-1 clones to infec-
tion by ALV subgroup A. For this, we constructed a
piggyBac transposon-based WT TVA overexpression vec-
tor (Fig. 4a). Next, we integrated a WT TVA overexpres-
sion cassette into tva-modified DF-1 clones (TVA#1–5,
TVA#1–6, and TVA#4–4) and WT DF-1 using piggyBac
transposase. Analysis of genomic DNA revealed that WT
TVA vector-transfected DF-1 lines contained the WT
TVA overexpression cassette (Fig. 4b).
Next, infected DF-1 cell lines with ALV subgroup A
and examined their susceptibility to infection. GFP ex-
pression was detected in WT TVA-overexpressing cell
lines (TVA#1–5 + TVA, TVA#1–6 + TVA, and TVA#4–
4 + TVA) (Fig. 4c). Quantitative analysis using flow cy-
tometry showed that GFP expression by WT TVA-
overexpressing groups was significantly higher than
that by tva-modified DF-1 clones, although there were
differences between the WT TVA-overexpressing
groups (Fig. 4d and e).
To further confirm the consequence of mutations on
tva for ALV subgroup A susceptibility, we establihsed
the DF-1 clones that express modified TVA receptor by
piggyBac transposon (Fig. 5a), then examined their sus-
ceptibility to infection. As results, GFP expression was
not significantly reduced in the modified TVA-overex-
pressing WT DF-1 cell lines (WT + TVA (+ 1), WT +
TVA (− 3), WT + TVA (Δ1–6)). And, we established the
modified TVA receptor-overexpressing DF-1 cell lines
from the DF-1 clones that already have a 3-bp pair dele-
tion on tva gene (TVA#1–5). The results of viral chal-
lenge in the cell lines showed that ALV subgroup A
susceptibility can not be restored by overexpression of
the modified TVA receptors in tva-modified DF-1 clone
(TVA#1–5 + TVA (+ 1), TVA#1–5 + TVA (− 3), TVA#1–
5 + TVA (Δ1–6)) (Fig. 5b, c and d).
Fig. 2 Targeted disruption of the tva gene in DF-1 fibroblasts using the CRISPR/Cas9 system. a The gene structure of tva (CD320) and the locus
targeted by CRISPR/Cas9 vectors (TVA#1 and TVA#4). Scale bar = 1 kb. b T7E1 assay of DF-1 cells transfected with the TVA#1 and TVA#4 CRISPR/
Cas9 vectors. Wild type (WT) DF-1 fibroblasts were used as the control. c Sequence analysis of transfected DF-1 cells using the TA cloning
method. Gray lowercase letters indicate insertions, and gray letters with lines indicate deletions. Indel mutations and their frequencies are
presented. Blue bars indicate guide RNA binding sites and red bars indicate protospacer adjacent motif (PAM) sequences
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Fig. 3 (See legend on next page.)
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Sequential disruption of host receptors for ALV
subgroups A, B and J and subsequent virus challenge
In previous studies, we showed that artificially generat-
ing a premature stop codon in the cysteine-rich domain
(CRD) of the tvb gene confers resistance to ALV sub-
group B [19], and that deletion of chNHE1 Trp38 con-
fers resistance to ALV subgroup J [20]. Therefore, we
examined whether sequential editing of the tva, tvb, and
chNHE1 genes confers resistance to ALV subgroups A,
B, and J simultaneously.
To induce sequential disruption of host receptors (tva,
tvb, and chNHE1), we used a N3Pss#12 DF-1 clone in
which chNHE1 Trp38 was deleted [20]. Sequential trans-
fection of CRISPR/Cas9 vectors targeting the tvb and
Fig. 4 Overexpression of the wild-type (WT) TVA receptor restores susceptibility of tva-modified DF-1 clones to infection by ALV subgroup A. a
Schematic representation showing the wild-type TVA receptor (WT TVA) overexpression cassette. 5′-TR: piggyBac 5′-terminal repeat; Neo: neomycin
resistant gene; CMV: cytomegalovirus promoter; WT TVA: WT TVA coding sequence; 3′-TR: piggyBac 3′-terminal repeat; Amp: ampicillin resistant gene;
CAGG: cytomegalovirus (CMV) enhancer fused to the chicken beta-actin promoter; PBase: piggyBac transposase coding sequence. b
Analysis of genomic DNA to confirm integration of the WT TVA overexpression cassette under specific PCR conditions. GAPDH was used
as a control. c Expression of GFP by virus-infected DF-1 clones. Three DF-1 clones (TVA#1–5, TVA#1–6, and TVA#4–4) and WT DF-1 cells
were transfected with the WT TVA overexpression cassette and then infected with ALV subgroup A. GFP expression by each group was
examined under a fluorescence microscope. Scale bar = 100 μm. d, e Flow cytometry analysis of virus-infected DF-1 clones. Gray peaks
indicate the population of WT cells not infected with ALV subgroup A (negative control) and green peaks indicate the population of DF-1 clones
infected with ALV subgroup A. The numbers on the histograms represent the mean percentage of cells within that population of triplicate replications.
WT DF-1 fibroblasts were used as the control (positive control). Different letters (a, b and c) indicate significant differences (P < 0.05)
(See figure on previous page.)
Fig. 3 Infection of tva-modified DF-1 clones with avian leukosis virus subgroup A, followed by flow cytometry analysis. a Expression of GFP by
virus-infected DF-1 clones. Eight DF-1 clones were examined under a fluorescence microscope. Scale bar = 100 μm. b, c Flow cytometry analysis
of virus-infected DF-1 clones. Gray peaks indicate the population of wild-type (WT) cells not infected with ALV subgroup A (negative control) and
green peaks indicate the population of ALV subgroup A-infected DF-1 clones. The numbers on the histograms represent the mean percentage of
cells within that population of triplicate replications. WT DF-1 fibroblasts were used as the control (positive control). c Data represent the mean ±
SEM of triplicate replications. Different letters (a, b) indicate significant differences (P < 0.05). d Multiple-sequence alignment of the four chicken
Tva receptor isoforms with the quail Tva receptor. Conserved residues are indicated by the asterisks (identical residues) and dots (similar residues)
below the aligned sequences. The quadrangle denotes the viral receptor domain of quail Tva, and the numbers on LDLR class A domain denote
the order of quail Tva amino acid sequences. Sequence alignment analysis was conducted using the UniProt consortium. e Comparative analysis
of deduced amino acids of tva-modified DF-1 clones. Quail Tva and chicken Tva amino acid are used as references. Tva amino acids of the in-
frame tva-modified DF-1 clones are presented. TVA#1–2 clone has mutations on the 64th and the 65th positions of Tva amino acid, TVA#1–5 clone
has mutation on 65th position of Tva amino acid and TVA#1–7 clone has large deletions on from the 55th to 68th positions of Tva amino acid
sequences. Different amino acids are highlighted. The numbers denote the order of quail Tva amino acid sequences
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Fig. 5 (See legend on next page.)
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tva genes into the chNHE1-modified clone generated
DF-1 clones harboring nucleic acid mutations in the tva,
tvb, and chNHE1 genes. First, we confirmed that the
N3Pss#12 DF-1 clone harbored a mutation in chNHE1
by sequencing a PCR product amplified from the target
region (Additional file 1: Figure S2A) [20]. Next, we con-
firmed that the N3Pss#12 + TVB#2 clone harbored an
8-bp deletion in the tvb gene that generated a premature
stop codon (Additional file 1: Figure S2B). Finally, we
confirmed that the three DF-1 clones (N3Pss#12 +
TVB#2 + TVA#1–6, N3Pss#12 + TVB#2 + TVA#1–8, and
N3Pss#12 + TVB#2 + TVA#4–8) established by sequen-
tial transfection of CRISPR/Cas9 vectors targeting tvb
and tva harbored the same mutations in tvb as the
N3Pss#12 + TVB#2 clones, as well as the same deletion
mutations in the tva gene (Additional file 1: Figure S2C)
and the mutations in the chNHE1 (Table 3).
Challenge of chNHE1, tvb, and tva-modified DF-1 clones
with ALV subgroup A, B and J
To identify the susceptibility of chNHE1-, tvb-, and tva-
modified DF-1 clones to infection by ALV, we infected
each clone with GFP-expressing marker viruses belong-
ing to ALV subgroups A, B, and J, respectively. GFP ex-
pression was detected when the chNHE1-modified clone
(N3Pss#12) was infected with either ALV subgroup A
and B, but not upon infection with ALV subgroup J. In
addition, GFP expression was detected only when
chNHE1/tvb-modified clones (N3Pss#12 + TVB#2) were
infected with ALV subgroup A, but not upon infection
with ALV subgroups B and J. No GFP expression was
detected in chNHE1/tvb/tva-modified DF-1 clones
(N3Pss#12 + TVB#2 + TVA#1–6, N3Pss#12 + TVB#2 +
TVA#1–8, and N3Pss#12 + TVB#2 + TVA#4–8) after in-
fection by ALV subgroups A, B, and J (Fig. 6a). Subse-
quent flow cytometry analysis showed marked GFP
expression by DF-1 clones harboring WT host genes
(Fig. 6b and c).
Discussion
Successfully controlling infectious diseases is one of the
most important challenges facing the poultry industry.
Enhancing economic traits using programmable genome
editing technologies such as CRISPR/Cas9 has merit in
terms of reducing the time required to generate a de-
sired genotype in livestock species [23]. In particular,
programmable genome editing technology can be ap-
plied directly to develop resistance to specific viral dis-
eases such as ALV, for which the host receptors have
been identified. Here, we used genome editing technol-
ogy to develop cell lines that are resistance to infection
by multiple ALVs; this step will precede development of
genome-edited chicken lines.
As reported previously, ALV subgroup A enters host
cells via the TVA receptor [7]. Deletion of introns from
the tva gene disrupts mRNA splicing and/or induces
frameshift mutations in exon 2, thereby altering host cell
susceptibility to infection by ALV subgroup A [13–15].
Here, we induced a frameshift mutation into the tva
gene rather than modifying the intron region to confer
resistance to ALV subgroup A. The two CRISPR/Cas9
vector constructs used induced nucleic acid mutations
within the targeted regions, and the pattern of mutations
correspond to those observed in our previous studies
[19, 20]. The results indicated that the CRISPR/Cas9--
based gene editing system is an efficient tool for target-
ing specific regions of the chicken genome. However, we
were unable to induce the exact mutation in the tva
gene that is reported to confer resistance [13]. The ex-
periments could be improved by using HDR-based ap-
proaches as well as by evaluating off-target mutations.
By contrast, the results of virus challenge experiments
showed that nucleotide mutations in the tva gene that
result in frameshift mutations are crucial for ALV sub-
group A entry. The TVA receptor belongs to LDLR fam-
ily; indeed, the LDLa plays an important role in receptor
function [24]. Exon 2 of the tva gene contains the LDLa;
therefore, we suggest that frameshift mutations causing
disruption of the LDLa domain would lead to misfolding
of the TVA protein. Furthermore, the results of virus
challenge experiments in Asp67-deleted (TVA#1–5) and
Asp67- and Glu68-deleted (TVA#1–2) DF-1 clones
(these mutations do not cause a frameshift) also con-
ferred resistance to ALV subgroup A. These results
(See figure on previous page.)
Fig. 5 a Schematic representation showing the wild-type TVA receptor (WT TVA) and modified TVA receptor (TVA(+ 1), TVA(− 3) and TVA(Δ1–6))
overexpression cassette and sequencing results of the constructed vector. CMV promoter and TVA CDS sequences are described, and modified
nucleic acids are highlighted. 5′-TR: piggyBac 5′-terminal repeat; Neo: neomycin resistant gene; CMV: cytomegalovirus promoter; 3′-TR: piggyBac 3′-
terminal repeat; Amp: ampicillin resistant gene; CAGG: cytomegalovirus (CMV) enhancer fused to the chicken beta-actin promoter; PBase: piggyBac
transposase coding sequence. b Expression of GFP by virus-infected DF-1 clones. WT TVA or modified TVA receptors overexpessing WT DF-1 cell lines
(WT, WT + TVA, WT + TVA(+ 1), WT + TVA(− 3) and WT+ TVA(Δ1–6)) and tva-modified DF-1 clones (3 bp deletion on tvb) (TVA#1–5, TVA#1–5 + TVA,
TVA#1–5 + TVA (+ 1), TVA#1–5 + TVA(− 3) and TVA#1–5 + TVA(Δ1–6)) were examined under a fluorescence microscope. Scale bar = 100 μm. c, d Flow
cytometry analysis of virus-infected DF-1 clones. Gray peaks indicate the population of the DF-1 not infected with ALV subgroup A (negative control;
WTni and TVA#1-5ni) and green peaks indicate the population of ALV subgroup A-infected DF-1 clones. The numbers on the histograms represent the
mean percentage of cells within that population of triplicate replications. WT DF-1 fibroblasts were used as the control (positive control). d Data
represent the mean ± SEM of triplicate replications. Different letters (a, b) indicate significant differences (P < 0.05)
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correspond with those published in previous studies
examining ALV-A susceptibility linked to the TVA recep-
tor [25]; two acidic amino acids in the carboxy-terminal
portion of TVA receptor and the frameshift mutations are
indispensable for infection by ALV subgroup A. Previous
studies show that Trp52, Asp55, His57, Asp59, Asp65,
and Glu66 of the quail TVA protein are calcium-
coordinating sites for the TVA LDL-A module and are
Fig. 6 Infection of chNHE1, tvb, and tva-modified DF-1 clones with avian leukosis virus subgroup A, B, and J, followed by flow cytometry analysis.
a Expression of GFP by virus-infected DF-1 clones. Five DF-1 clones were examined under a fluorescence microscope. Scale bar = 100 μm. b, c
Flow cytometry analysis of virus-infected DF-1 clones. Gray peaks indicate the population of wild-type (WT) cells not infected with ALV subgroup
A (negative control) and green peaks indicate the population of DF-1 clones infected by ALV subgroup A. The numbers on the histograms
represent the mean of triplicate replications. WT DF-1 fibroblasts were used as the control (positive control). c Data represent the mean ± SEM of
triplicate replications. Different letters (a, b) indicate significant differences (P < 0.05)
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required for proper protein folding. Furthermore, His57
and Trp67 of the quail TVA protein act as viral contact
residues and are involved directly in binding to EnvA [26,
27]. Protein structure analysis revealed that the LDLR re-
gion harboring these residues is highly conserved in differ-
ent chicken TVA receptor isoforms. These results suggest
that the in-frame tva-modified DF-1 clones have impaired
function due to improper protein folding caused by a lack
of calcium binding residues. Also, they do not bind to
EnvA due to lack of viral contact residues. Moreover, we
showed that overexpression of WT TVA restores suscepti-
bility to infection by ALV subgroup A viruses. However,
differences in susceptibility were noted between cell lines
containing the WT TVA overexpression cassette, possibly
due to the differences in piggyBac integration sites and
copy number of transgene [22]. Meanwhile, modified
TVA receptors could not restore susceptibility to infection
by ALV subgroup A viruses in tva-modified DF-1 clone.
Taken together, the results indicate that the TVA receptor
is necessary for entry of ALV subgroup A viruses and
could therefore be targeted to alter the immune character-
istics of poultry flocks.
We also found that sequential disruption of ALV host
receptors chNHE1, TVB, and TVA confers resistance to
ALV subgroups A, B and J, respectively. We examined this
by modifying the host receptor genes in chicken DF-1 fi-
broblasts by sequential introduction of CRISPR/Cas9 gene
editing vectors. The results demonstrated that altering
multiple genes can be achieved; this technique can then
be used to develop multiple gene knock-out cell lines.
Subsequent virus infection experiments showed that dis-
ruptions of the tva-, tvb-, and chNHE1-encoded receptors
conferred simultaneous resistance to ALV subgroups A, B
and J. As expected, the results also confirmed that ALV
subgroups A, B and J do not share the same receptors for
entry into cells, despite the close sequence similarity be-
tween ALV subgroups A and B [28]. By understanding in-
teractions between ALVs and host receptors at the genetic
level we may be able to predict likely host receptors for
any emerging subgroup of ALV.
Conclusion
We conducted multiplex genome editing of chicken
DF-1 fibroblasts and showed that sequential disruption
of host receptors for ALV subgroups A, B, and J confers
resistance. To gain further insight into virus-host inter-
actions, as well as into virus evolution, we will analyze
the susceptibility of these cells to other virus subgroups
(such as ALV subgroup C and the recently reported sub-
group K). As a next step, we will apply the genome edit-
ing strategy to germline competent cells, including
primordial germ cells or spermatogonial stem cells [29,
30], to generate novel multi-disease resistant chicken
lines as an approach to controlling major avian diseases.
Indeed, NHE1-null fibroblasts show impaired homeosta-
sis, manifested by reduced adhesion, loss of polarity, and
reduced motility and chemotaxis [31]. However, chicken
cell lines naturally resistant to ALV subgroups A and B
are available (e.g., inbred chicken line C and line 72), as
are avian species harboring mutations in the Trp38 of
the NHE1 receptor [13, 18]. These results suggest that
the ALV host receptors may be not be critical, or that
other receptors compensate for a specific function of
each receptor. To evaluate the function of each receptor,
physiological and molecular analyses of immune re-
sponses and cell homeostasis in receptor gene-modified
cells or birds are needed.
Additional file
Additional file 1: Figure S1. Sequences of the targeted regions within
tva-modified DF-1 clones. Red arrows indicate TVA#1 and TVA#4 targeting
regions. A reference sequence is shown. Figure S2. Sequences of targeted
regions within (a) chNHE1, (b) chNHE1 and tvb, and (c) chNHE1, tvb, and
tva-modified DF-1 clones. Red arrows indicate the (a) NHE1#3, (b) TVB#2,
and (c) TVA#1 and TVA#4 targeting regions. Reference sequences are
shown. (DOCX 848 kb)
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